BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)

CUSIP: 07782B104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Ordinary Shares, par value US$0.0001 per share
Shares outstanding
37,379,062
Total 13F shares
155,109
Share change
+54,536
Total reported value
$7,095,600
Price per share
$45.75
Number of holders
17
Value change
+$3,531,143
Number of buys
13
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q4 2023

As of 31 Dec 2023, BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 155,109 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, MORGAN STANLEY, STATE STREET CORP, Cubist Systematic Strategies, LLC, MARSHALL WACE, LLP, JPMORGAN CHASE & CO, Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, Jump Financial, LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 17 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.